Skip to main content

Illumina s Earnings to Exceed Expectations in Q1

NEW YORK, April 7 (GenomeWeb News) - Illumina had better revenue and earnings in the first quarter than expected, the company said yesterday.


Illumina said it expects to exceed both its revenue and net income per share guidance for the first quarter of 2006. In February, the company said it expected between $22 million and $24 million in revenues, and income between $0 and $0.02 per basic and diluted share in the first quarter.


Illumina did not disclose the updated projections, but said it will release its first-quarter earnings on April 18 after the close of market.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.